Why the study?
Do the optical enantiomers of verapamil reduce ischemia-induced arrhythmias in a rat model?
Do the optical enantiomers of verapamil reduce ischemia-induced arrhythmias in a rat model?
The optical enantiomers of verapamil dose-dependently reduce ischemia-induced ventricular arrhythmias in rats, with (-)-verapamil being more potent, supporting the antiarrhythmic role of calcium antagonism during acute myocardial ischemia.
May support calcium antagonism in ischemia-induced arrhythmias; hypothesis-generating in rat model, clinical translation needed.
The actions of (-)-verapamil (0.2-6 mg kg-1) and (+)-verapamil (0.4-12 mg kg-1) against arrhythmias induced by coronary artery occlusion were studied in conscious rats. Intravenously administered (-)- and (+)-verapamil dose-dependently reduced ventricular arrhythmias. (-)-Verapamil was consistently 4 times more potent than (+)-verapamil. In the same animals, (-)-verapamil was approximately 4 times more potent than (+)-verapamil for effects on heart rate and blood pressure. Both enantiomers prolonged P-R interval, but had no effect on QRS interval. In separate groups of conscious rats, neither enantiomer influenced the threshold voltage and pulse width required to elicit fibrillo-flutter, or altered the maximum following frequency, during electrical stimulation of the left ventricle. In isolated, paced, Langendorff-perfused ventricles of the rat, both enantiomers dose-dependently reduced contractility, (-)-verapamil being 8-21 times more potent than (+)-verapamil; both absolute and relative potencies were dependent on potassium concentration. These results are compatible with the hypothesis that calcium antagonism in the ischaemic ventricular myocardium is antiarrhythmic during acute myocardial ischaemia.
No takes yet. Share an insight, caveat, or question.
Curtis et al. (1986) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: